BlueCrest Capital Management Ltd raised its position in AmerisourceBergen Corp. (NYSE:ABC) by 50.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,886 shares of the company’s stock after acquiring an additional 3,650 shares during the period. BlueCrest Capital Management Ltd’s holdings in AmerisourceBergen were worth $1,000,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. BlackRock Inc. raised its holdings in shares of AmerisourceBergen by 5.8% in the fourth quarter. BlackRock Inc. now owns 12,384,803 shares of the company’s stock worth $1,137,171,000 after buying an additional 679,417 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of AmerisourceBergen by 107.3% in the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock worth $434,385,000 after buying an additional 2,776,287 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of AmerisourceBergen by 11.4% in the third quarter. Wells Fargo & Company MN now owns 3,726,377 shares of the company’s stock worth $308,358,000 after buying an additional 381,936 shares during the last quarter. Harding Loevner LP raised its holdings in shares of AmerisourceBergen by 89.6% in the third quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock worth $134,939,000 after buying an additional 1,496,761 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of AmerisourceBergen by 23.8% in the fourth quarter. Bank of New York Mellon Corp now owns 2,864,488 shares of the company’s stock worth $263,016,000 after buying an additional 550,215 shares during the last quarter. Institutional investors own 67.33% of the company’s stock.
In other AmerisourceBergen news, insider Peyton R. Howell sold 17,800 shares of AmerisourceBergen stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $89.70, for a total value of $1,596,660.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Dale Danilewitz sold 3,121 shares of AmerisourceBergen stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $92.12, for a total transaction of $287,506.52. The disclosure for this sale can be found here. Insiders sold 177,609 shares of company stock valued at $16,855,249 in the last ninety days. 27.30% of the stock is owned by corporate insiders.
AmerisourceBergen Corp. (ABC) opened at $100.60 on Wednesday. AmerisourceBergen Corp. has a fifty-two week low of $71.90 and a fifty-two week high of $106.27. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50. The firm has a market cap of $22,100.00, a price-to-earnings ratio of 57.49, a price-to-earnings-growth ratio of 1.48 and a beta of 1.03.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The company had revenue of $40.47 billion during the quarter, compared to analysts’ expectations of $40.42 billion. During the same quarter in the previous year, the company earned $1.36 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. equities research analysts expect that AmerisourceBergen Corp. will post 6.58 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th were issued a $0.38 dividend. The ex-dividend date was Friday, February 16th. This represents a $1.52 dividend on an annualized basis and a yield of 1.51%. AmerisourceBergen’s payout ratio is 86.86%.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.